Food and Drug Regulations (C.R.C., c. 870)

Regulations are current to 2013-05-20 and last amended on 2013-03-21. Previous Versions

C.01.041.3. The pharmacist to whom a prescription for a Schedule F Drug is transferred under section C.01.041.1 shall retain in his files for a period of two years the information and documents referred to in section C.01.041.2.

  • SOR/78-424, s. 3.

C.01.041.4. A pharmacist who transfers a prescription under section C.01.041.1

  • (a) shall enter on the original of the prescription or in a suitable record of prescription kept under the name of each patient, the date of transfer; and

  • (b) shall not make any further sales under the prescription nor transfer it to another pharmacist.

  • SOR/78-424, s. 3.

  • C.01.042. (1) No person shall refill a prescription for a Schedule F Drug unless the practitioner so directs and no person shall refill such a prescription more times than the number of times prescribed by the practitioner.

  • (2) The person filling or refilling a prescription for a Schedule F Drug shall enter on the original of the prescription or in a suitable record of prescriptions kept under the name of each patient

    • (a) the date of filling;

    • (b) the date of each refill, if applicable;

    • (c) the quantity of drug dispensed at the original filling and each refill; and

    • (d) his name.

  • SOR/78-424, s. 4.

  • C.01.043. (1) A person may sell a Schedule F Drug, without having received a prescription therefor, to

    • (a) a drug manufacturer;

    • (b) a practitioner;

    • (c) a wholesale druggist;

    • (d) a registered pharmacist;

    • (e) a hospital certified by the Department of National Health and Welfare;

    • (f) a Department of the Government of Canada or of a province, upon receipt of a written order signed by the Minister thereof or his duly authorized representative; or

    • (g) any person, upon receipt of a written order signed by the Director.

  • (2) Where a person makes a sale authorized by paragraph (1)(f) or (1)(g), he shall retain the written order for the drug for a period of at least two years from the date of filling the order.

  • C.01.044. (1) Where a person advertises to the general public a Schedule F Drug, the person shall not make any representation other than with respect to the brand name, proper name, common name, price and quantity of the drug.

  • (2) Subsection (1) does not apply where

    • (a) the drug is listed in Part II of Schedule F; and

    • (b) the drug is

      • (i) in a form not suitable for human use, or

      • (ii) labelled in the manner prescribed by paragraph C.01.046(b).

  • SOR/78-424, s. 5;
  • SOR/93-202, s. 7;
  • SOR/93-407, s. 3.